| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy
|
Yao, Isaac
|
|
2019
|
202 |
C |
p. 32-39
|
article
|
| 2 |
Chronopharmacological strategies focused on chrono-drug discovery
|
Ohdo, Shigehiro
|
|
2019
|
202 |
C |
p. 72-90
|
article
|
| 3 |
Cognitive dysfunction in major depression: From assessment to novel therapies
|
Atique-Ur-Rehman, Hafsa
|
|
2019
|
202 |
C |
p. 53-71
|
article
|
| 4 |
Drugging K-RasG12C through covalent inhibitors: Mission possible?
|
Ni, Duan
|
|
2019
|
202 |
C |
p. 1-17
|
article
|
| 5 |
Drug resistance in non-small cell lung Cancer (NSCLC): Impact of genetic and non-genetic alterations on therapeutic regimen and responsiveness
|
Terlizzi, Michela
|
|
2019
|
202 |
C |
p. 140-148
|
article
|
| 6 |
Editorial Board
|
|
|
2019
|
202 |
C |
p. ii
|
article
|
| 7 |
Histamine beyond its effects on allergy: Potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS)
|
Volonté, Cinzia
|
|
2019
|
202 |
C |
p. 120-131
|
article
|
| 8 |
Laminin-derived peptides: Applications in drug delivery systems for targeting
|
Negishi, Yoichi
|
|
2019
|
202 |
C |
p. 91-97
|
article
|
| 9 |
Live cell imaging of signaling and metabolic activities
|
Depaoli, Maria R.
|
|
2019
|
202 |
C |
p. 98-119
|
article
|
| 10 |
Molecular mechanisms of cereblon-based drugs
|
Asatsuma-Okumura, Tomoko
|
|
2019
|
202 |
C |
p. 132-139
|
article
|
| 11 |
Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease – frontiers and horizons
|
Jee, Adelle S.
|
|
2019
|
202 |
C |
p. 40-52
|
article
|
| 12 |
TP53 in bone and soft tissue sarcomas
|
Thoenen, Elizabeth
|
|
2019
|
202 |
C |
p. 149-164
|
article
|
| 13 |
Vascular Disrupting Agents in cancer treatment: Cardiovascular toxicity and implications for co-administration with other cancer chemotherapeutics
|
Gill, Jason H.
|
|
2019
|
202 |
C |
p. 18-31
|
article
|
Journal description